I tried a 50 pack (2 a day) and I did not notice any improvements, so did not purchase another package.
Hopwever, I do see that this personal trial of mine is missing a few "end points". I was basically monitoring for improvements in EDSS, over short period. The other "end points" a proper study may consider, and may be the point of benefit for this are:
Maybe it would reduce the number of relapses?
Maybe it would reduce the severity of relapses when they do occur?
Maybe it would help relapses resolve quicker?
I did note in another thread, an article I found that specifically talked about it with MS, and although I did not read it again yet, the quote I took out appears top implicate a 6month use of daflon; was it run by the manufacturers?
The ThreadThe study paperThe Quote
Quote:
After adjusting the baseline values of either group to 100%, a statistically significant difference in favour of the enzymes was demonstrated from the sixth month (p < .01 ), an even highly significant difference at end of therapy (p < .001 ).
If the difference at baseline is judged as clinically so relevant that a direct comparison during the course of the therapy is not acceptable, there is nevertheless a difference in favor of the enzymes in the change of the Kurtzke scale: whereas the value improved until the last available value in the enzyme group by 24.2% (from 3.3 to 2.5), it worsened in the corticosteroid group by (-)2.2% from 4.5 to 4.6.
Maybe its the combination treatment of Daflon AND patience....